These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8687111)

  • 21. Arousal of mucosal secretory immunoglobulin A antitoxin in rats immunized with Escherichia coli heat-labile enterotoxin.
    Klipstein FA; Engert RF; Clements JD
    Infect Immun; 1982 Sep; 37(3):1086-92. PubMed ID: 7129629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune response to a mucosally administered aflatoxin B1 vaccine.
    Wilkinson J; Rood D; Minior D; Guillard K; Darre M; Silbart LK
    Poult Sci; 2003 Oct; 82(10):1565-72. PubMed ID: 14601734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholera toxin as a mucosal adjuvant. Glutaraldehyde treatment dissociates adjuvanticity from toxicity.
    Liang XP; Lamm ME; Nedrud JG
    J Immunol; 1989 Jul; 143(2):484-90. PubMed ID: 2544646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mucosal immune response to an HIV C4/V3 peptide following nasal or intestinal immunization of rabbits.
    Winchell JM; Van Kruiningen HJ; Silbart LK
    AIDS Res Hum Retroviruses; 1997 Jul; 13(10):881-9. PubMed ID: 9197382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variables affecting the local immune response in Thiry-Vella loops. II. Stability of antigen-specific IgG and secretory IgA in acute and chronic Thiry-Vella loops.
    Keren DF; Scott PJ; Bauer D
    J Immunol; 1980 Jun; 124(6):2620-4. PubMed ID: 6154734
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficient extracellular production of recombinant Escherichia coli heat-labile enterotoxin B subunit by using the expression/secretion system of Bacillus brevis and its mucosal immunoadjuvanticity.
    Kozuka S; Yasuda Y; Isaka M; Masaki N; Taniguchi T; Matano K; Moriyama A; Ohkuma K; Goto N; Udaka S; Tochikubo K
    Vaccine; 2000 Mar; 18(17):1730-7. PubMed ID: 10699320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunoglobulins A and G in the intestinal secretions of rats in different microbiologic conditions].
    Ruban SZ; Chakhova OV; Shustrova NM
    Biull Eksp Biol Med; 1981 Jul; 92(7):66-8. PubMed ID: 6794663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IgA antibodies in rat bile inhibit cholera toxin-induced secretion in ileal loops in situ.
    Tamaru T; Brown WR
    Immunology; 1985 Aug; 55(4):579-83. PubMed ID: 4018842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective transport of serum-derived IgA into mucosal secretions.
    Sheldrake RF; Husband AJ; Watson DL; Cripps AW
    J Immunol; 1984 Jan; 132(1):363-8. PubMed ID: 6690604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mucosal IgA elaboration.
    Keren DF
    Crit Rev Clin Lab Sci; 1989; 27(2):159-77. PubMed ID: 2656093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kefir milk enhances intestinal immunity in young but not old rats.
    Thoreux K; Schmucker DL
    J Nutr; 2001 Mar; 131(3):807-12. PubMed ID: 11238763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Local (immunoglobulin A) immune response by the intestine to cholera toxin and its partial suppression with combined systemic and intra-intestinal immunization.
    Yardley JH; Keren DF; Hamilton SR; Brown GD
    Infect Immun; 1978 Feb; 19(2):589-97. PubMed ID: 631891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mucosal immunization via M cells for production of protective secretory IgA antibodies.
    Neutra MR; Kraehenbuhl JP
    Am J Trop Med Hyg; 1994; 50(5 Suppl):10-3. PubMed ID: 8203718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significance of immune responses to mucosal carcinogens: a hypothesis and a workable model system.
    Keren DF; Silbart LK; Lincoln PM; Annesley TM
    Pathol Immunopathol Res; 1986; 5(3-5):265-77. PubMed ID: 3601874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutralization of cholera toxin by rat bile secretory IgA antibodies.
    Vaerman JP; Derijck-Langendries A; Rits M; Delacroix D
    Immunology; 1985 Mar; 54(3):601-3. PubMed ID: 3918935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholera toxin as a mucosal adjuvant: effects of H-2 major histocompatibility complex and lps genes.
    Elson CO
    Infect Immun; 1992 Jul; 60(7):2874-9. PubMed ID: 1612753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Mucosal Adjuvant Activities of ADP-Ribosylating Bacterial Enterotoxins.
    Snider DP
    Crit Rev Immunol; 2017; 37(2-6):499-530. PubMed ID: 29773032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Secretory immunoglobulin A response to Shiga toxin in rabbits: kinetics of the initial mucosal immune response and inhibition of toxicity in vitro and in vivo.
    Keren DF; Brown JE; McDonald RA; Wassef JS
    Infect Immun; 1989 Jul; 57(7):1885-9. PubMed ID: 2659525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of a dietary protein in E. coli renders it strongly antigenic to gut lymphoid tissue.
    Dahlgren UI; Wold AE; Hanson LA; Midtvedt T
    Immunology; 1991 Aug; 73(4):394-7. PubMed ID: 1916891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mucosal barrier mechanisms. Interplay between secretory IgA (SIgA), IgG and mucins on the surface properties and association of salmonellae with intestine and granulocytes.
    Magnusson KE; Stjernström I
    Immunology; 1982 Feb; 45(2):239-48. PubMed ID: 7037617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.